PIROXICAM IN THE TREATMENT OF PRIMARY DYSMENORRHEA

L. Wilhelmsson, K. Jönsson, Luo Hailing, L. Hailing, Martin Hermann, J. Jäderling, C. Lindell, Björn Nilsson, F. Sannum, Anders Haglund
In: Acta Obstetricia et Gynecologica Scandinavica · 1985 · vol. 64(4) , pp. 317–321 · doi:10.3109/00016348509155138 · PMID:3895810 · W2135751478
article OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Piroxicam was found to be comparable to naproxen sodium and significantly better than placebo in treating primary dysmenorrhea across several efficacy and safety parameters.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

In double-blind, crossover studies, piroxicam was compared with naproxen sodium and with placebo. The different parameters studied were pain intensity, patient's opinion of the drugs tested, complementary pharmacological treatment, ability to work, overall effect, treatment preference, and side effects. It was concluded that piroxicam was comparable to naproxen sodium and that piroxicam was significantly better than placebo, as regards these parameters. It was also concluded that piroxicam has an effect equivalent to that of naproxen sodium, an accepted treatment for dysmenorrhea.

My notes (saved in your browser only)

Condition tags

dysmenorrhea

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

Cited by (2)

References (12)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-01T06:38:16.588661+00:00
License: CC0 · commercial use OK